STEPHANIE OWENS: Open Payments
NPI 1881460129 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,296 in 13 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $445 · 2025 $1,296
Food & beverage: $1,296
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $521 |
| AstraZeneca Pharmaceuticals LP | 2 | $218 |
| Janssen Pharmaceuticals, Inc | 1 | $126 |
| Alkermes, Inc. | 1 | $122 |
| Phathom Pharmaceuticals, Inc. | 1 | $104 |
| Lilly USA, LLC | 1 | $96 |
| Otsuka America Pharmaceutical, Inc. | 1 | $92 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: UZEDY, SPRAVATO, LYBALVI, AIRSUPRA, VOQUEZNA, BREZTRI, ZEPBOUND, REXULTI.
Industry payments across NM — which companies pay providers there.
